Walleye Capital LLC Abb Vie Inc. Call Options Transaction History

Walleye Capital LLC

$46.2 Billion
Q3 2024

Call Options

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $6.47 Million - $7.87 Million	39,500 Added 41.89%	133,800 $26.4 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $19.1 Million - $22.4 Million	-123,700 Reduced 56.74%	94,300 $16.2 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $17.5 Million - $19.9 Million	109,200 Added 100.37%	218,000 $39.7 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $5.71 Million - $6.43 Million	-41,500 Reduced 27.61%	108,800 $16.9 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $12.2 Million - $14.1 Million	91,100 Added 153.89%	150,300 $22.4 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $1.13 Million - $1.4 Million	8,500 Added 16.77%	59,200 $7.98 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $1.1 Million - $1.27 Million	7,600 Added 17.63%	50,700 $8.08 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $1.92 Million - $2.31 Million	13,900 Added 47.6%	43,100 $6.97 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $3.92 Million - $4.49 Million	29,200 New	29,200 $3.92 Million
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $667,667 - $893,438	-9,100 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $18.8 Million - $28.5 Million	-291,000 Reduced 96.97%	9,100 $693,000
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $3.92 Million - $4.91 Million	54,400 Added 22.14%	300,100 $26.6 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $10.7 Million - $12.8 Million	169,400 Added 222.02%	245,700 $18.6 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $1.98 Million - $2.53 Million	30,100 Added 65.15%	76,300 $5.55 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $3.56 Million - $4.19 Million	46,200 New	46,200 $3.72 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Account